People · Operator
Named in public records as an officer, director or promoter · active 2010–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Applied Proteomics, Inc. | — | Biotechnology | Series B | $50.4M | $1.1B | 2013 |
| View Point Medical, Inc. | — | Biotechnology | Series B | $30.0M | $32.5M | 2019 |
| Predictive Biosciences, Inc | — | Biotechnology | Series B | $26.8M | $1.0B | 2010 |
Peter Klemm at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Peter Klemm on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Langer | 1 | 36 |
| Michael Greeley | 1 | 15 |
| Robert S Langer | 1 | 14 |
| James C. Blair | 1 | 8 |
| James Blair | 1 | 8 |
| Josh Baltzell | 1 | 7 |
| James Barrett | 1 | 6 |
| M. James Barrett | 1 | 6 |
| Bijan Salehizadeh | 1 | 5 |
| Jay Moorin | 1 | 4 |
| Vikram Lamba | 1 | 4 |
| Jeffrey Port | 1 | 4 |
| Kim Blickenstaff | 1 | 3 |
| David Agus | 1 | 3 |
| Gary Pace | 1 | 3 |
| Ellen E. Sheets | 1 | 2 |
| Kok Thay Lim | 1 | 2 |
| William Blair | 1 | 2 |
| Marsha Moses | 1 | 1 |
| Anthony P Shuber | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.